文献速递肺外科

临床IA1-2期NSCLC肺段切除术后局部区域复发的危险因素:真实临床实践分析

Risk Factors Associated With Locoregional Recurrence Following Pulmonary Segmentectomy for Clinical Stage IA1-2 NSCLC: A Real Clinical Practice Analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2026-01-01

本研究回顾性分析2017至2024年287例临床IA1-2期病理确诊NSCLC行肺段切除术患者,评估无事件生存、总生存及复发模式。4年OS为80%,EFS为69.5%,复发31例(10.8%),以局部区域复发为主(26例,9.1%)。切缘<5 mm与局部区域复发显著相关,PET高代谢及纯实性肿瘤亦与较差EFS相关。

要点

  • 肺段切除术治疗IA1-2期NSCLC后局部区域复发为主,切缘<5 mm者复发率显著升高。
  • PET SUVmax>2.5及纯实性肿瘤形态与较差无事件生存相关。
  • 术前仔细规划与个体化手术策略对保证肿瘤学切除至关重要。

核心结论

  • 充分的切除切缘是降低IA期NSCLC肺段切除术后局部区域复发的关键。
  • PET代谢活性与肿瘤形态可进一步分层复发风险。

研究设计与样本

  • 回顾性分析2017至2024年连续287例临床IA1-2期病理确诊NSCLC行肺段切除术的患者。
  • 评估无事件生存、总生存及复发模式,采用Cox回归和竞争风险模型分析不良结局相关因素。

主要发现

  • 4年总生存率为80%(95%CI 73-87),4年无事件生存率为69.5%(95%CI 61-77)。
  • 31例(10.8%)出现复发,其中局部区域复发26例(9.1%)。
  • 切缘<5 mm者局部区域复发率为20.3%,切缘≥5 mm者为5.8%(P<.001)。
  • 竞争风险分析显示切缘<5 mm与复发独立相关(P=.009)。
  • PET SUVmax>2.5者4年EFS为60%(95%CI 48-70),SUVmax≤2.5者为81%(95%CI 69-89)(P=.0001);纯实性肿瘤EFS为61%(IQR 45-74),含亚实性成分者为73%(IQR 62-81)(P=.039)。

关键数值与推荐

  • 切缘<5 mm定义为短切缘,与局部区域复发独立相关(P=.009)。
  • PET SUVmax>2.5定义为高代谢,与较差EFS相关(P=.0001)。
  • 纯实性肿瘤对比含亚实性成分肿瘤,EFS较差(P=.039)。

临床怎么用

  • 肺段切除术中应确保充分切缘(≥5 mm)以降低局部区域复发风险。
  • 术前PET SUVmax>2.5或纯实性肿瘤患者需更谨慎评估与个体化手术规划。

局限性

  • 回顾性单中心设计,样本量有限,结论需外部验证。
  • 原文摘要未报告其他局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The oncological role of anatomic segmentectomy in early-stage non-small-cell lung cancer (NSCLC) remains under active investigation. We sought to identify predictors of recurrence following segmentectomy in patients with clinical stage IA1-2 NSCLC. METHODS: We retrospectively analysed consecutive patients who underwent segmentectomy for clinical stage IA1-2 pathologically confirmed NSCLC between 2017 and 2024. Event-free survival (EFS), overall survival (OS), and recurrence patterns were assessed. Cox regression and competing risk models were applied to determine factors associated with adverse outcomes. RESULTS: A total of 287 patients were included. Four-year OS and EFS were 80% (95% confidence interval [CI], 73-87) and 69.5% (95% CI, 61-77), respectively. Recurrence occurred in 31 patients (10.8%), predominantly loco-regional (n = 26, 9.1%). Patients with resection margins <5 mm had significantly higher rates of loco-regional recurrence compared with those with wider margins (20.3% vs 5.8%, P < .001). On competing risk analysis, a short margin (<5 mm) was independently associated with recurrence (P = .009). Poorer EFS was also observed in patients with hypermetabolic tumours on positron emission tomography (PET) (standardized uptake value maximum [SUVmax] > 2.5 vs ≤2.5: 60% [95% CI, 48-70] vs 81% [95% CI, 69-89]; P = .0001) and in pure solid tumours compared with those with a subsolid component (61% [IQR, 45-74] vs 73% [IQR, 62-81]; P = .039). CONCLUSIONS: Adequate resection margins are critical to reduce loco-regional recurrence after segmentectomy for stage IA NSCLC. PET avidity and tumour morphology further stratify recurrence risk. Careful preoperative planning and tailored surgical strategies are essential to ensure oncologically sound resections.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Hurley PD, Chaudhuri N, Lodhia J, et al. Risk Factors Associated With Locoregional Recurrence Following Pulmonary Segmentectomy for Clinical Stage IA1-2 NSCLC: A Real Clinical Practice Analysis. Eur J Cardiothorac Surg. 2026. PMID: 41390919. doi:10.1093/ejcts/ezaf442

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。